Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retin...
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
This retrospective study aimed to investigate the progression of central retinal vein occlusion (CVO) prior to treatment initiation and its impact on prognosis. Of the 54 studied eyes with acute CVO, the average logMAR visual acuity (VA) at the initial visit was 0.65 ± 0.49 with an average time to treatment of 14.9 ± 14.5 days. VA at the initial tr...
Alternative Titles
Full title
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_71d9eddd9a56408e963a619e800a7195
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_71d9eddd9a56408e963a619e800a7195
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-67925-7
